Intubating Laryngeal Mask vs Direct Laryngoscopy: a Crossover Randomized Controlled Preterm Manikin Trial
Launched by UNIVERSITY HOSPITAL PADOVA · Feb 8, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to compare two methods of helping newborns breathe when they have trouble: using an intubating laryngeal mask and a technique called direct laryngoscopy. The study will take place using a manikin that looks and acts like a newborn baby. Researchers want to find out which method is more successful and quicker, as well as gather opinions from healthcare providers on how they feel about each approach.
Eligible participants for this trial are doctors and residents who work in a Level III Neonatal Intensive Care Unit (NICU), which is a specialized unit for caring for sick or premature newborns. There are no specific exclusions, so anyone meeting the criteria can take part. If you join the trial, you’ll have the chance to practice both intubation techniques on a manikin and share your thoughts on each method. This research is important because it could help improve care for newborns who need intubation in real situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Level III NICU consultants and residents will be eligible to participate in the study
- Exclusion Criteria:
- • None
About University Hospital Padova
University Hospital Padova is a leading research institution in Italy, renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. As a prominent academic medical center, it integrates cutting-edge research with comprehensive healthcare services, fostering collaboration among multidisciplinary teams of experts. The hospital is dedicated to ethical research practices and patient safety, striving to translate scientific discoveries into effective treatments. With a strong emphasis on education and training, University Hospital Padova plays a pivotal role in shaping the future of medicine while contributing to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported